SIGNAL GENETICS INC |
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 05-09 | Oppenheimer Adjusts Viridian Therapeutics Price Target to $31 From $36, Maintains Outperform Rating | MT |
| 05-09 | B. Riley Downgrades Viridian Therapeutics to Neutral From Buy | MT |
Chart calendar Signal Genetics Inc
2ff415b7a9fa3cd743bd4095cde.Glja0gT9YGHGJjuMGkty6tLY0T7_VUHYHnpr1_GKUwc.fD-5u0irGhLyQg21UCI0oo3suQvGYReLfB4umJrtCV1IaJeNdrQsOZIXbg~0d6d08588709e4bbb8c4789e7ab3843b
Upcoming events on Signal Genetics Inc
Past events on Signal Genetics Inc
| 2024-05-08 08:00 | Q1 2024 Earnings Call |
| 2024-05-08 07:00 | Q1 2024 Earnings Release |
| 2024-03-11 14:00 | Leerink Partners Global Biopharma Conference |
| 2024-03-05 15:15 | North American Neuro Ophthalmology Society Meeting |
| 2024-03-05 12:00 | North American Neuro Ophthalmology Society Meeting |
| 2024-01-11 10:30 | JPMorgan Healthcare Conference |
| 2023-12-18 08:00 | VRDN-003 IGF-1R Clinical Trial Results Call |
| 2023-11-30 11:15 | Evercore ISI HealthCONx Conference |
| 2023-11-15 11:00 | Jefferies London Healthcare Conference - Fireside Chat |
| 2023-11-13 16:01 | Q3 2023 Earnings Release |
| 2023-11-05 18:45 | American Academy of Ophthalmology Meeting |
| 2023-11-04 12:45 | American Academy of Ophthalmology Meeting |
| 2023-11-02 | American Academy Of Ophthalmology Meeting |
| 2023-09-28 13:50 | American Thyroid Association Meeting |
| 2023-09-16 03:35 | European Society of Ophthalmic Plastic and Reconstructive Surgery Meeting |
| 2023-09-15 08:20 | European Society of Ophthalmic Plastic and Reconstructive Surgery Meeting |
| 2023-09-11 08:52 | European Thyroid Association Meeting |
| 2023-09-11 08:40 | European Thyroid Association Meeting |
| 2023-08-08 16:01 | Q2 2023 Earnings Release |
| 2023-07-10 17:00 | VRDN-001 Phase 1/2 Clinical Trial Results Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 4,46 4,32 3.38% | 1,05 1,05 0.42% | 2,96 3,12 -5.11% | 1,77 2,13 -16.98% | 0,31 0,39 -18.44% | 0,23 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -65,1 -58,8 -10.86% | -134 -105 -28.12% | -187 -184 -1.58% | -195 |
|
EBIT Million USD | Released Forecast Spread | -42,0 -41,5 -1.26% | -110 -26,4 -318.14% | -79,7 -68,4 -16.63% | -134 -116 -15.74% | -254 -238 -7.09% | -249 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -41,9 -41,3 -1.39% | -111 -26,9 -311.37% | -79,4 -68,2 -16.47% | -130 -114 -14.34% | -238 -224 -6.2% | -231 |
|
Net income Million USD | Released Forecast Spread | -41,9 -41,3 -1.39% | -111 -26,7 -315.12% | -79,4 -68,7 -15.61% | -130 -115 -13.26% | -238 -224 -6.32% | -226 |
|
EPS USD | Released Forecast Spread | -20,1 -17,1 -17.34% | -31,1 -3,18 -879.55% | -6,68 -6,42 -4.08% | -4,05 -3,57 -13.52% | -5,31 -4,94 -7.46% | -3,66 |
| Announcement Date | 11/03/20 | 26/03/21 | 10/03/22 | 08/03/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,22 0,25 -14.79% | 0,26 0,23 10.48% | 1,20 0,26 359.62% | 0,11 0,46 -77.05% | 0,10 0,00 - | 0,07 0,20 -63.18% | 0,07 0,10 -29.01% | 0,07 0,15 -53.3% | 0,07 0,08 -9.81% | 0,06 | 0,06 | 0,06 | 0,12 | 0,12 |
|
EBITDA Million USD | Released Forecast Spread | -21,2 -19,5 -8.71% | -24,6 -20,1 -22.41% | -24,8 -25,3 1.81% | -49,0 -26,2 -87.16% | -57,2 -37,0 -54.46% | -46,8 -31,5 -48.7% | -51,1 -43,5 -17.45% | -45,3 -42,0 -7.81% | -43,1 -33,6 -28.03% | -46,9 | -50,9 | -54,0 | ||
|
EBIT Million USD | Released Forecast Spread | -25,9 -23,2 -11.36% | -29,6 -25,2 -17.1% | -29,8 -30,9 3.62% | -49,1 -30,8 -59.09% | -72,5 -47,1 -54.03% | -59,3 -54,1 -9.56% | -51,2 -58,2 11.99% | -71,5 -54,7 -30.77% | -55,9 -67,0 16.58% | -62,2 | -64,2 | -66,3 | -74,5 | -77,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -25,7 -23,6 -8.75% | -29,5 -24,9 -18.5% | -28,9 -29,3 1.3% | -45,8 -29,5 -55.18% | -68,2 -43,7 -56.13% | -55,1 -48,2 -14.16% | -47,7 -54,9 13.23% | -66,9 -51,3 -30.34% | -48,5 -61,1 20.61% | -59,6 | -61,9 | -64,2 | -67,7 | -68,2 |
|
Net income Million USD | Released Forecast Spread | -25,7 -24,5 -4.82% | -29,5 -25,4 -16.3% | -28,9 -30,8 6.06% | -45,8 -30,3 -51.03% | -68,2 -46,9 -45.39% | -55,1 -53,3 -3.32% | -47,7 -54,2 12.11% | -66,9 -51,8 -29.17% | -48,5 -62,5 22.3% | -57,7 | -61,2 | -62,3 | -67,7 | -68,2 |
|
EPS USD | Released Forecast Spread | -0,98 -1,00 2% | -1,06 -0,89 -19.55% | -0,86 -0,98 12.5% | -1,13 -0,73 -54.79% | -1,61 -0,96 -68.29% | -1,27 -1,24 -2.27% | -1,09 -1,24 11.88% | -1,35 -1,01 -34.22% | -0,79 -1,07 26.23% | -0,90 | -0,95 | -0,95 | -0,97 | -0,98 |
| Announcement Date | 12/05/22 | 15/08/22 | 14/11/22 | 08/03/23 | 10/05/23 | 08/08/23 | 13/11/23 | 27/02/24 | 08/05/24 | - | - | - | - | - |
More events
Past sector events for Signal Genetics Inc
| 2024-05-10 07:00 | HUMACYTE, INC.: Q1 2024 Earnings Release |
| 2024-05-09 | NOVAVAX, INC.: Q1 2024 Earnings Release |
| 2024-05-09 | TAKARA BIO INC.: Q4 2023 Earnings Release |
| 2024-05-09 | CHABIOTECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-05-09 16:10 | GYRE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:05 | ARS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:05 | HILLEVAX, INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:05 | BIOHAVEN LTD.: Q1 2024 Earnings Release |
| 2024-05-09 16:05 | OMNIAB, INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:05 | 4D MOLECULAR THERAPEUTICS, INC.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- VRDN Stock
- Stock
- Calendar Signal Genetics Inc